Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
clinical research collaboration
Biotech
Regeneron swoops in with $2B biobucks pact for troubled CytomX
Cytomx was in need of a project after abandoning its lead asset and embarking on a pipeline rebuild. Enter Regeneron.
Annalee Armstrong
Nov 17, 2022 9:40am
Exscientia tapped by MD Anderson for AI drug discovery efforts
Nov 14, 2022 10:34am
Synaffix allies with Emergence in $360M biobuck ADC pact
Sep 6, 2022 8:50am
Merck is back in Alzheimer's saddle with $1B-plus Cerevance pact
Aug 9, 2022 10:00am
Basilea returns cancer drug rights to Merck
Jun 27, 2022 11:18am
Bristol Myers triples-down on Immatics, bringing deal to $4.2B
Jun 2, 2022 11:48am
